You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三生製藥(01530.HK)擬購回2022年到期可換股債券及建議發行新可換股債券
格隆匯 06-17 19:34

格隆匯6月17日丨三生製藥(01530.HK)公佈,發行人建議進行購回最多達發行在外的現有於2022年到期的零票息可換股債券的本金總額。於2020年6月17日,發行人、公司及聯席交易經辦人訂立交易經辦人協議,據此,發行人及公司已委任聯席交易經辦人協助識別及聯絡現有可換股債券的持有人,以及向有關持有人遊説招攬要約出售現有可換股債券。

同步購回與建議新債券發行將同步進行,並將於新債券發行日期或前後結束。於同步購回結算後,已購回的現有可換股債券將被註銷。

同步購回的同時,發行人建議向機構投資者發行新債券。倘發行人進行建議新債券發行,發行人擬將建議新債券發行的所得款項淨額用於同步購回或現有可換股債券持有人於行使認沽期權後贖回現有可換股債券而所需的付款、研發、購買營運設施及用作其他一般企業用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account